Ecolab Inc. vs Huntsman Corporation — Stock Comparison
Q·Score Breakdown
6.6
Neutral
Overall
4.2
Bearish
Quality
Health
Growth
Valuation
Sentiment
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
HUN
Healthy balance sheet and financial position.
⚠ elevated valuation at 76× forward P/E.
Analyst Consensus
BUY
Target $317.48 (+22.3%)
21 analysts
HOLD
Target $13.00 (-11.1%)
13 analysts
Fundamentals
ECL
HUN
35.1×
Trailing P/E
—
27.1×
Forward P/E
75.9×
12.8%
Profit Margin
-5.8%
44.4%
Gross Margin
12.9%
22.4%
ROE
-8.9%
10.0%
Revenue Growth
0.7%
7.8%
Earnings Growth
—
1.02
Beta
—
—
Price / Book
—
$73.3B
Market Cap
$2.5B
$249 – $309
52-Week Range
$7 – $16
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →